España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Y-mAbs Therapeutics
YMAB
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$11.14
-0.45
-3.88%
At close: -
$11.14
0
0.00%
After Hours: Nov 15, 5:35 PM EDT
Get Report
Comment
Y-mAbs Therapeutics (YMAB) Forecast
News
Earnings
Y-mAbs Therapeutics (YMAB) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Y-mAbs Therapeutics (NASDAQ:YMAB) Stock
Y-mAbs Therapeutics Stock (NASDAQ: YMAB)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, November 15, 2024
HC Wainwright & Co. Reiterates Buy on Y-mAbs ...
Benzinga Newsdesk
Friday, November 08, 2024
Y-mAbs Anticipates 2024 Total Net Revenues Of...
Benzinga Newsdesk
Y-mAbs Therapeutics Q3 2024 GAAP EPS $(0.16),...
Benzinga Newsdesk
Thursday, November 07, 2024
Examining the Future: Y-mAbs Therapeutics's Earnings Outlook
Benzinga Insights
Monday, November 04, 2024
Y-mAbs Therapeutics And Nobelpharma Entered I...
Benzinga Newsdesk
Wednesday, October 30, 2024
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
Vandana Singh
Tuesday, September 10, 2024
Wedbush Reiterates Outperform on Y-mAbs Thera...
Benzinga Newsdesk
Monday, September 09, 2024
Navigating 8 Analyst Ratings For Y-mAbs Therapeutics
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on Y-...
Benzinga Newsdesk
Friday, September 06, 2024
Y-mAbs Therapeutics Announced New Clinical An...
Nabaparna Bhattacharya
Friday, August 16, 2024
Cantor Fitzgerald Initiates Coverage On Y-mAb...
Benzinga Newsdesk
Wednesday, August 14, 2024
Y-mAbs Therapeutics shares are trading. The s...
Benzinga Newsdesk
Tuesday, August 13, 2024
Canaccord Genuity Maintains Buy on Y-mAbs The...
Benzinga Newsdesk
Assessing Y-mAbs Therapeutics: Insights From 5 Financial Analysts
Benzinga Insights
Morgan Stanley Maintains Underweight on Y-mAb...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Y-mAbs ...
Benzinga Newsdesk
BMO Capital Maintains Outperform on Y-mAbs Th...
Benzinga Newsdesk
Monday, August 12, 2024
Y-mAbs Therapeutics, Inc. Reports Q2 Loss, Misses Revenue Estimates
Zacks
Y-mAbs Therapeutics shares are trading lower ...
Benzinga Newsdesk
Y-mAbs' Cash And Cash Equivalents Of $77.8M H...
Benzinga Newsdesk
Y-mAbs' Anticipated 2024 Total Net Revenues N...
Benzinga Newsdesk
Y-mAbs Therapeutics Q2 2024 GAAP EPS $(0.21) ...
Benzinga Newsdesk
Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Thursday, July 11, 2024
Jones Trading Initiates Coverage On Y-mAbs Th...
Benzinga Newsdesk
Tuesday, July 02, 2024
MSC Industrial Direct, Radius Recycling And 3 Stocks To Watch Heading Into Tuesday
Avi Kapoor
Monday, July 01, 2024
Y-mAbs Therapeutics Appoints Peter Pfreundsch...
Benzinga Newsdesk
Friday, June 28, 2024
Truist Securities Initiates Coverage On Y-mAb...
Benzinga Newsdesk
Friday, June 07, 2024
Y-MAbs Therapeutics Says Preclinical GD2-SADA...
Benzinga Newsdesk
Monday, May 13, 2024
HC Wainwright & Co. Maintains Buy on Y-mAbs T...
Benzinga Newsdesk
Tuesday, May 07, 2024
Y-mAbs Reiterates Guidance
Benzinga Newsdesk
Y-mAbs Therapeutics Q1 2024 GAAP EPS $(0.15) ...
Benzinga Newsdesk
Thursday, March 14, 2024
Y-mAbs Therapeutics Announces Resignation Of ...
Benzinga Newsdesk
Wednesday, March 06, 2024
Cracking The Code: Understanding Analyst Reviews For Y-mAbs Therapeutics
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Y-mAbs T...
Benzinga Newsdesk
Monday, March 04, 2024
Canaccord Genuity Maintains Buy on Y-mAbs The...
Benzinga Newsdesk
BMO Capital Maintains Outperform on Y-mAbs Th...
Benzinga Newsdesk
Friday, March 01, 2024
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
Avi Kapoor
Why NetApp Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Thursday, February 29, 2024
Y-mAbs Therapeutics Q4 2023 GAAP EPS $(0.020)...
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Earnings Scheduled For February 29, 2024
Benzinga Insights
Wednesday, February 28, 2024
Earnings Outlook For Y-mAbs Therapeutics
Benzinga Insights
Tuesday, February 20, 2024
HC Wainwright & Co. Maintains Buy on Y-mAbs T...
Benzinga Newsdesk
Monday, January 15, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Friday, January 12, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Thursday, November 30, 2023
521K Reasons To Be Bullish On Y-mAbs Therapeutics Stock
Benzinga Insights
Y-mAbs Therapeutics Director Makes $521K Stock Purchase
Benzinga Insights
Wednesday, November 15, 2023
HC Wainwright & Co. Reiterates Buy on Y-mAbs ...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch